%20PRIVATE%20LIMITED-67598%2015-Dec-2008_files/image002.jpg){kind=small}
- Summary Information
|
Company Name |
BIOTRON HEALTHCARE (INDIA) PRIVATE LIMITED |
Principal Name 1 |
MRS. GAYATHRI RANGANATHAN |
|
Status |
SMALL COMPANY |
Principal Name 2 |
MR. VANKATESH VOLET |
|
Street Address |
301, CORAL CLASSIC, 20TH ROAD, CHEMBUR, MUMBAI-400071,
MAHARASHTRA, INDIA |
||
|
Established Date |
10.08.1998 |
SIC Code |
-- |
|
Telephone# |
91-22-25287626/ 25281015 |
Business Style 1 |
DISTRIBUTOR |
|
Fax # |
91-22-25281012 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
GENOMICS AND PROTEOMICS |
|
|
# of employees |
-- |
Product Name 2 |
DRUG DISCOVERY AND SCREENING |
|
Paid up capital |
Rs. 210000 |
Product Name 3 |
MOLECULAR BIOLOGY AND
DIAGNOSTICS |
|
Shareholders |
DIRECTORS OR
RELATIVES OF DIRECTORS ( 100%) |
Banking |
CORPORATION BANK |
|
Public Limited Corp. |
NO |
Business Period |
10 YEARS |
|
IPO |
NO |
International Ins. |
- |
|
Public Enterprise |
NO |
Rating |
B |
|
Related Company |
|||
|
Relation |
Country |
Company Name |
CEO |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2007 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
16181000 |
Current Liabilities |
18816000 |
|
Inventories |
9440000 |
Long-term Liabilities |
9452000 |
|
Fixed Assets |
5173000 |
Other Liabilities |
000 |
|
Deferred Assets |
000 |
Total Liabilities |
28268000 |
|
Invest& other Assets |
5000 |
Retained Earnings |
2321000 |
|
|
|
Net Worth |
2531000 |
|
Total Assets |
30799000 |
Total Liab. & Equity |
30799000 |
|
Total Assets (Previous Year) |
23836000 |
|
|
|
P/L Statement as of |
31.03.2007 |
(Unit: Indian Rs.) |
|
|
Sales |
Not Available |
Net Profit |
1000000 |
|
Sales(Previous yr) |
Not Available |
Net Profit(Prev.yr) |
799000 |
MIRA
INFORM REPORT
|
Report Date : |
15.12.2008 |
IDENTIFICATION
DETAILS
|
Name : |
BIOTRON HEALTHCARE (INDIA) PRIVATE LIMITED |
|
|
|
|
Registered Office : |
301, Coral Classic, 20th Road, Chembur, Mumbai-400071,
Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
10.08.1998 |
|
|
|
|
Com. Reg. No.: |
11-11675 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U33100MH1998PTC116175 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMB08735G |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCB1398N |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Distributor of Quality/Innovative Products,
Technology and Services. |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 12000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a relatively small company in its field. Trade relations
are fair. Scale of activity is limited. No complaints have been heard. The company can be considered for small to mediocre business dealings. |
LOCATIONS
|
Registered Office : |
301, Coral Classic, 20th Road, Chembur, Mumbai-400071,
Maharashtra, India |
|
Tel. No.: |
91-22-25287626/ 25281015 |
|
Fax No.: |
91-22-25281012 |
|
E-Mail : |
techicals@biotronhealthcare.com |
|
Website : |
|
|
|
|
|
Regional Office : |
301, Corporate Tower, 85A, Bhardwaz Plaza, Zamrud Pur, Greter Kailash-I,
New Delhi-110048, India |
|
Fax No.: |
91-11-41727975 |
|
E-Mail : |
|
|
|
|
|
Branches : |
Located At:- ·
Ahmedabad ·
Bangalore ·
Chennai ·
Lucknow ·
Hyderabad ·
Chandigarh ·
Kolkata |
DIRECTORS
|
Name : |
Mrs. Gayathri Ranganathan |
|
Designation : |
Director |
|
Address : |
A-2, Mira Building, 2, Road, Chembur, Mumbai-400071, Maharashtra,
India |
|
|
|
|
Name : |
Mr. Vankatesh Voleti |
|
Designation : |
Director |
|
Address : |
C-30, 3rd Lake View, Building No. 4, Pawai Vihar Complex, A
S Road, Powai, Mumbai-400076, Maharashtra, India |
|
|
|
|
Name : |
Mr. Shrikant Hangal |
|
Designation : |
Director |
|
Address : |
603, Lasende A 302, Lok Angan CHS, Mulund (West), Mumbai-400080,
Maharashtra, India |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 30.08.2007
|
Names of Shareholders |
|
No. of Shares |
|
Gayathri Ranganathan |
|
7000 |
|
Venkatesh Voleti |
|
7000 |
|
Shrikant Hanga |
|
7000 |
|
Total |
|
21000 |
Equity Share Breakup (Percentage of Total Equity)
As on 30.09.2007
|
Category |
|
Percentage |
|
Directors or relatives of directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Distributor of Quality/Innovative Products,
Technology and Services. |
|
|
|
|
Products : |
Genomics and Proteomics - Microarray Setup, 2D Gel systems,
Biochips, consumables, etc. Drug Discovery and Screening - Multi-label Detection systems, Liquid
handling for screening, Screening kits etc. Molecular Biology and Diagnostics - Complete solution from Nucleic Acid
Isolation – Amplification –Detection-Reporting Liquid Handling - Low throughput to High throughput systems,
Blood Grouping Systems, Kit manufacturing set |
GENERAL
INFORMATION
|
Bankers : |
·
Corporation Bank, Chembur Branch, Tolaram Shopping Centre, Plot No.
95/C, N.G. Acharya Marg, Chembur, Mumbai-400071, Maharashtra, India ·
HDFC Bank |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Keshav F Jetsey Chartered Accounant |
|
Address : |
104, Sai Deep Building, Opposite Vaishali Hotel, Chembur, Mumbai-400071,
Maharashtra, India |
|
Tel. No.: |
91-22-25211789 |
|
Mobile No.: |
91-22-25212964/ 65 |
|
Fax No.: |
CAPITAL STRUCTURE
As on 29.09.2007
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50000 |
Equity Shares |
Rs. 10/- each |
Rs. 0.500 Million |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
21000 |
Equity Shares |
Rs. 10/-
each |
Rs. 0.210
Million |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.210 |
0.210 |
0.210 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
2.321 |
1.320 |
0.519 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
2.531 |
1.530 |
0.729 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
5.182 |
3.460 |
2.033 |
|
|
2] Unsecured Loans |
4.270 |
4.768 |
3.608 |
|
|
TOTAL BORROWING |
9.452 |
8.228 |
5.641 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
11.983 |
9.758 |
6.370 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
5.173 |
5.392 |
1.666 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.005 |
0.005 |
0.005 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
9.440
|
8.258 |
3.528 |
|
|
Sundry Debtors |
8.180
|
3.479 |
4.013 |
|
|
Cash & Bank Balances |
0.090
|
0.005 |
0.122 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
7.911
|
6.697 |
4.489 |
|
Total
Current Assets |
25.621
|
18.439 |
12.152 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
16.251
|
12.233 |
6.151 |
|
|
Provisions |
2.565
|
1.845 |
1.302 |
|
Total
Current Liabilities |
18.816
|
14.078 |
7.453 |
|
|
Net Current Assets |
6.805
|
4.361 |
4.699 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
11.983 |
9.758 |
6.370 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
|
|
Sales Turnover |
|
NA |
NA |
|
|
Other Income |
|
NA |
NA |
|
|
Total Income |
|
NA |
NA |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
1.566 |
1.049 |
|
|
Provision for Taxation |
|
0.567 |
0.250 |
|
|
Profit/(Loss) After Tax |
|
1.000 |
0.799 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Bank Charges |
|
0.776 |
0.259 |
|
|
Depreciation & Amortization |
|
0.737 |
0.478 |
|
Total Expenditure |
|
1.513 |
0.737 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
Return on Total Assets (PBT/Total Assets} |
(%) |
5.08
|
4.40 |
NA |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.62
|
0.69 |
NA |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
11.16
|
14.57 |
17.96 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
1.31 |
1.63 |
LOCAL AGENCY
FURTHER INFORMATION
The Register Office of the company has been shifted from 19th
Road Chembur, Mumbai-400071, Maharashtra, India to present address w.e.f.
01.06.2007
Bankers Charges
Report as per Registry
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified
|
80038495 |
|
Corporate
identity number of the company |
U33100MH1998PTC116175 |
|
Name of the
company |
BIOTRON HEALTHCARE (INDIA) PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in India of the company |
301, Coral Classic, 20th Road, Chembur, Mumbai-400071,
Maharashtra, India |
|
7Type of charge |
Immovable Property Any interest in
immovable property |
|
Particular of
charge holder |
Corporation Bank, Chembur Branch, Tolaram Shopping Centre, Plot No.
95/C, N.G. Acharya Marg, Chembur, Mumbai-400071, Maharashtra, India |
|
Nature of
description of the instrument creating or modifying the charge |
Continuity Letter
for extension of Mortgage |
|
Date of
instrument Creating the charge |
01.10.2007 |
|
Amount secured by
the charge |
Rs. 5.900
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest Interest @ 13.25%
p.a. Terms of
Repayment On demand Margin As per sanctioned
letter Extent and
Operation of the charge Security to
secure CC Rs. 4.500 Millions , BG Rs. 0.700 Millions , LC Rs. 0.700 Millions
together with interest, Cost, expenses, changes commission etc. |
|
Short particulars
of the property charged |
Equitable
Mortgage created by deposit of title deeds in respect of office premises No. 302,
on 3rd Floor admeasuring 540 sq.ft carpet area, coral Classic,
Plot No. 67A, 20th Road, S.No. 956 and 956/1, Chembur
,Mumbai-400071 |
Fixed Assets:
·
Furniture and Fixture
·
Computer
·
Mobile Phone
·
Fax Machine
·
EPABX System
·
Motor Car
·
Refrigerator
·
Telephone Instruments
·
Office Fans
·
Air Conditioners
·
Xerox PE – 16
·
Card Scan Executive
·
Deep Freezer
·
Office Premises
·
Labeling Machine
·
Microwave Oven
AS PER WEBSITE
Profile:
Subject was established in 1998 by a group of highly skilled,
vastly experienced and motivated professionals who now form the senior
management team. The team is supported by high caliber sales professionals and
engineers and a distributor network in the major cities of India and the
sub-continent.
Subject is engaged in the distribution of quality/innovative
products, technology and services from world leading manufacturers chosen
carefully for their brand value and strength of the company.
The
Products :
They broadly classify the product range in four main
categories :
Genomics and Proteomics
- Microarray Setup, 2D Gel systems, Biochips, consumables, etc.
Drug Discovery & Screening
- Multi-label Detection systems, Liquid handling for screening, Screening
kits, etc.
Molecular Biology & Diagnostics
- Complete solution from Nucleic Acid Isolation – Amplification
–Detection-Reporting
Liquid Handling
- Low throughput to High throughput systems, Blood Grouping Systems, Kit
manufacturing set
The Network :
They have established a good network of the own offices at
major cities in India with highly qualified and experienced professionals and
also have dealer network to cover interior places.
They believe in providing complete customer satisfaction
through the products, the knowledge, application support and experience. All
the engineers and product specialists are well trained at the principals /
manufacturing sites or at the site.
In-house Lab :
They have set up a modern fully equipped lab at the Mumbai
Head office to facilitate new product development, application support, trouble
shooting, demonstrations and training
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction registered
against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.71 |
|
UK Pound |
1 |
Rs.72.85 |
|
Euro |
1 |
Rs.64.70 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
34 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|